CRAC intermediate 2 T10885
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CRAC intermediate 2 is a intermediate compound for CRAC inhibitor synthesis. CRAC intermediate 2 has been extracted from patent WO 2013059666A1.
CAS nr:
123066-64-8
Purity:
98%
Molecular Weight:
295,18
SMILES:
NC1=CC=C(N2N=C(C(F)(F)F)C=C2C(F)(F)F)C=C1
Formula:
C11H7F6N3
Pathway:
Others,Membrane transporter/Ion channel,Metabolism
Target:
Others,Calcium Channel,Calcium Channel
